Overcoming Chemotherapy Resistance in Head and Neck Cancer using PI3K Inhibition
Head and neck squamous cell carcinoma (HNSCC) is almost uniformly fatal when it recurs following definitive treatment with chemoradiation. To address this critical therapeutic gap, our team investigated inhibition of the phosphoinositide 3-kinase (PI3K) pathway.